Implanet

What Implanet does

Implanet is a France-based medical technology company founded in 2007 and listed on Euronext Paris (ticker ALIMP), headquartered in Martillac near Bordeaux. It designs, manufactures, and markets orthopedic implants and surgical equipment focused on spinal surgery, serving spine surgeons and surgical centers in public hospitals, private clinics, and ambulatory surgery centers. As of 2025 the company reported full-year revenue of €12.5 million and employed 46 staff, with a stated international presence across 42 countries.

Implanet's product portfolio centers on the Jazz family of sublaminar braided spinal implants (Jazz Evo, Jazz Lock, Jazz Claw, Jazz PF, Jazz Passer, Jazz Frame, Jazz Spinal System), protected by four sets of international patents. Supporting the fixation line are the Zeus and Saxxo posterior fixation systems, the Swingo-T and Swingo-P bi-convex lumbar interbody cages (T-LIF and P-LIF), the Squale cervical cages, and the Origin anterior cervical plate. The Olea ultrasonic osteotome operates at 39 kHz with 120μm amplitude to enable controlled bone cutting in open and endoscopic procedures. All products are manufactured in Europe with CE marking, FDA 510(k) clearance, and ANVISA certification. The company is also co-developing a multi-arm spine surgery robotic system through a 2025 partnership with 8i Robotics.

Implanet generates revenue through direct hardware sales to healthcare facilities and through a distributor network spanning 42 countries, with dedicated direct sales in France and through its US subsidiary IMPLANET AMERICA in Memphis, Tennessee. The Olea product line is also distributed in the US via a partnership with Elliquence. Pricing is quotation-based through hospital procurement rather than published list pricing, and the company markets primarily through participation in spine surgery conferences (Eurospine, BSS, AANS, POSNA, IMAST, SFCR) and its Jazz Academy professional training program. Despite 33% revenue growth in 2025, Implanet remained unprofitable with an operating loss of -€4.2 million, and completed a €4.49 million capital increase in November 2025 to fund continued expansion including a new market entry into China.

Name

Implanet

Legal name

IMPLANET

Website

https://implanet.com

Company type

Public

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Implanet is a French medical technology company that designs, manufactures, and markets spinal implants (Jazz family) and ultrasonic surgical equipment (Olea) for orthopedic surgeons and hospitals across 42 countries, generating €12.5M in 2025 revenue with direct sales in France and the United States.

Ownership category

akta.pro rank

Product category

Spinal Implants and Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

akta.pro secondary industries

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC)

Keywords

• Spinal implant devices
• Orthopedic fixation systems
• Intervertebral fusion cages
• Ultrasonic osteotome equipment
• Spine surgery medical devices

Headquarters

HQ city

Martillac

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Spine Implants and Medical Equipment: IMPLANET generates revenue through the sale of spinal implants (fixation systems, intervertebral cages, instrumentation) and medical equipment including the Olea ultrasonic osteotome. The company sells directly to healthcare providers and through distribution partners globally.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Implanet designs, manufactures, and markets spinal and orthopedic implants and surgical equipment for healthcare professionals treating patients with spinal disorders. Its core offerings include the Jazz family of patented braided sublaminar posterior fixation implants (Jazz Evo, Jazz Lock, Jazz Claw, Jazz PF, Jazz Passer, Jazz Frame, Jazz Spinal System), complementary posterior fixation systems (Zeus, Saxxo), intervertebral fusion cages (Swingo-T, Swingo-P, Squale), the Origin anterior cervical plate, and the Olea ultrasonic osteotome for controlled bone cutting in open and endoscopic spine surgery.

Product overview

Implanet is a medical technology company specializing in orthopedic implants for spinal surgery. The product portfolio centers on the Jazz™ family of braided implants (including Jazz Evo, Jazz Lock, Jazz Claw, Jazz PF, Jazz Passer, Jazz Frame, and Jazz Spinal System) which serve as the core posterior fixation and scoliosis treatment platform. Supporting the fixation line are the Zeus and Saxxo posterior fixation systems. For intervertebral fusion, the company offers the Swingo-T and Swingo-P bi-convex cages (T-LIF and P-LIF approaches) and Squale cervical cages, complemented by the Origin anterior cervical plate system. The equipment portfolio features the Olea ultrasonic osteotome for controlled bone cutting in both open and endoscopic procedures. Products are organized by anatomical region (cervical, thoracic, lumbar) and product category (fixation, intervertebral fusion, instrumentation, equipment). All products are manufactured 100% in Europe and carry CE marking and/or FDA 510(k) clearance.

Differentiator

Problem solved

Functional benefit

Products and services

• Jazz Evo Posterior fixation system and Implanet's reference product for scoliosis treatment, featuring the latest-generation patented braided sublaminar implant technology. Designed for spine surgeons treating complex spinal deformities.
• Jazz Lock Multipurpose fixation system providing unique versatile fixation for spinal procedures, part of the Jazz braid implant family.
• Jazz Claw Fixation solution designed for constructs at the top of spinal fixation systems.
• Jazz PF Tethering solution for spinal deformity treatment, providing durable construct fixation.
• Jazz Passer Posterior fixation device for spinal stabilization procedures.
• Jazz Frame Spinal fixation frame system for posterior stabilization.
• Jazz Spinal System Hybrid posterior fixation system combining multiple fixation approaches for comprehensive spinal support, marketed to US spine surgeons under the Jazz brand.
• Zeus Posterior fixation system featuring a hybrid design for spinal stabilization.
• Saxxo Posterior fixation system designed for short construct spinal procedures.
• Olea
• Swingo-T Anatomical bi-convex T-LIF (Transforaminal Lumbar Interbody Fusion) cages for lumbar spine fusion procedures.
• Swingo-P Anatomical bi-convex P-LIF (Posterior Lumbar Interbody Fusion) cages for lumbar spine fusion procedures.
• Squale Cervical interbody fusion cages for cervical spine fusion procedures.
• Origin Locking anterior cervical plate system for anterior cervical fixation and stabilization.

Quantifiable outcome

• Revenue growth of 33% in 2025 to €12.5 million
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• 8i Robotics Inc.coreStrategic or Co-development Partner · 1 November 2025Partnership for clinical evaluation of a surgeon-supervised multi-arm robotic system designed for spine surgery. First milestone involves clinical research with leading French hospitals to achieve European regulatory compliance (CE mark). The system is described as the world's first multi-arm humanoid surgical robot with electromagnetic navigation and integrated digital microscope. Medium-term goal is market launch in Europe.
• ElliquencecoreChannel Partner/ Reseller/ Distributor · 1 September 2024Partnership for US distribution of the Ultrasonic Bone Scalpel Olea designed for endoscopic spine procedures. The partnership combines Elliquence's Surgi-Max Ultra platform with Implanet's ultrasonic bone scalpel technology for the US market.

Scale indicators6 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Spineart: Geneva-based privately held spine implant company with a comparable focus on cervical and lumbar fusion devices, sold through direct sales and distributors. Closest peer by size, European origin, and product overlap with Implanet's Jazz and Swingo lines.
• Alphatec Spine: US publicly traded spine-focused company (ATEC on Nasdaq) targeting the same surgeon base with posterior fixation, interbody, and biologics portfolios. Comparable in scale and pure-play spine focus to Implanet.
• Xtant Medical: US-listed small-cap spine and orthopedic company selling fixation and biologics through distributors. Similar revenue scale to Implanet and similar go-to-market model in the US.

Regional players

• Spineway: French-listed small-cap spine implant company focused on premium disc and cervical devices. Comparable by scale and European public-market profile, though product portfolio skews toward motion-preservation rather than fusion.

Broad incumbents

• Stryker (Spine division): Global medical device major with a substantial spine and neurosurgery business, including posterior fixation, interbody, and cervical systems. Sets the competitive ceiling for Implanet's posterior fixation portfolio and employs several of Implanet's alumni.
• Medtronic (Spine): World's largest spine implant franchise (legacy Kyphon/Mazor), covering the full spectrum from cervical to deformity correction. The principal incumbent against which Implanet's scoliosis-focused Jazz system competes in complex procedures.
• Globus Medical (incl. NuVasive): Large spine pure-play formed via the NuVasive merger, with leading positions in posterior fixation, interbody, and enabling technology. Direct competitive overlap with Implanet's posterior fixation and interbody cage lines.
• Zimmer Biomet: Diversified orthopedic major with a meaningful spine portfolio across cervical, thoracolumbar, and deformity segments. Competes broadly with Implanet across hospital procurement cycles in EMEA and the US.
• Orthofix: US-listed orthopedic and spine company offering fixation, biologics, and motion-preservation products. Mid-sized incumbent with comparable surgeon-customer profile to Implanet, especially in complex spine and pediatric deformity.

Emerging players

• SI-BONE: US-listed company focused on minimally invasive sacroiliac joint fusion using proprietary implant technology. Comparable as a small-cap, single-segment-focused spine/orthopedic device company pursuing differentiated surgical solutions outside the mainstream fusion market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks2 records

Key highlights1 record

Customer concentration

• LinkedInlinkedin.com/company/implanet

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds9 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Implanet